CN103721131B - 一种治疗妇女慢性***的中药栓剂及其制备方法 - Google Patents
一种治疗妇女慢性***的中药栓剂及其制备方法 Download PDFInfo
- Publication number
- CN103721131B CN103721131B CN201310746423.3A CN201310746423A CN103721131B CN 103721131 B CN103721131 B CN 103721131B CN 201310746423 A CN201310746423 A CN 201310746423A CN 103721131 B CN103721131 B CN 103721131B
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- suppository
- chinese medicine
- inflammatory disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 103
- 239000000829 suppository Substances 0.000 title claims abstract description 71
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 title claims abstract description 54
- 230000001684 chronic effect Effects 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims description 27
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 24
- 241000050051 Chelone glabra Species 0.000 claims abstract description 21
- 244000289376 Rhus trilobata Species 0.000 claims abstract description 17
- 235000016935 Rhus trilobata var. trilobata Nutrition 0.000 claims abstract description 17
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 17
- 235000005412 red sage Nutrition 0.000 claims abstract description 17
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 16
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 16
- 241000746375 Andrographis Species 0.000 claims abstract description 15
- 241001649190 Campsis Species 0.000 claims abstract description 15
- 241000628997 Flos Species 0.000 claims abstract description 15
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 15
- 235000011034 Rubus glaucus Nutrition 0.000 claims abstract description 15
- 235000009122 Rubus idaeus Nutrition 0.000 claims abstract description 15
- 241000245665 Taraxacum Species 0.000 claims abstract description 15
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 14
- 240000000249 Morus alba Species 0.000 claims abstract description 14
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 14
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 14
- 239000009910 sargent gloryvine Substances 0.000 claims abstract description 14
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 13
- 240000009022 Smilax rotundifolia Species 0.000 claims abstract description 13
- 235000003205 Smilax rotundifolia Nutrition 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 244000235659 Rubus idaeus Species 0.000 claims abstract description 6
- 240000002045 Guettarda speciosa Species 0.000 claims abstract 9
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 4
- 229920000742 Cotton Polymers 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- 229940079593 drug Drugs 0.000 claims description 25
- 238000010438 heat treatment Methods 0.000 claims description 25
- 239000011159 matrix material Substances 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 240000007890 Leonurus cardiaca Species 0.000 claims description 15
- 238000000605 extraction Methods 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 14
- 238000001816 cooling Methods 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 13
- 238000010992 reflux Methods 0.000 claims description 10
- 238000002844 melting Methods 0.000 claims description 9
- 230000008018 melting Effects 0.000 claims description 9
- 238000007493 shaping process Methods 0.000 claims description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 8
- 239000004033 plastic Substances 0.000 claims description 8
- 229920003023 plastic Polymers 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 239000002674 ointment Substances 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 7
- -1 polyoxyethylene Polymers 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims description 5
- 241000700605 Viruses Species 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 5
- 239000013618 particulate matter Substances 0.000 claims description 5
- 229920001983 poloxamer Polymers 0.000 claims description 5
- 229960000502 poloxamer Drugs 0.000 claims description 5
- 239000004166 Lanolin Substances 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 4
- 230000008025 crystallization Effects 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 4
- 238000003780 insertion Methods 0.000 claims description 4
- 230000037431 insertion Effects 0.000 claims description 4
- 229940039717 lanolin Drugs 0.000 claims description 4
- 235000019388 lanolin Nutrition 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000010410 dusting Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000001256 steam distillation Methods 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 86
- 210000004369 blood Anatomy 0.000 abstract description 84
- 230000000694 effects Effects 0.000 abstract description 47
- 238000011282 treatment Methods 0.000 abstract description 46
- 201000010099 disease Diseases 0.000 abstract description 41
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 41
- 230000001737 promoting effect Effects 0.000 abstract description 20
- 230000017531 blood circulation Effects 0.000 abstract description 19
- 208000024891 symptom Diseases 0.000 abstract description 19
- 230000008901 benefit Effects 0.000 abstract description 13
- 208000025661 ovarian cyst Diseases 0.000 abstract description 7
- 206010046914 Vaginal infection Diseases 0.000 abstract description 5
- 238000011084 recovery Methods 0.000 abstract description 5
- 206010049677 Salpingo-oophoritis Diseases 0.000 abstract description 4
- 201000008100 Vaginitis Diseases 0.000 abstract description 4
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 40
- 230000036407 pain Effects 0.000 description 38
- 238000012360 testing method Methods 0.000 description 25
- 210000004291 uterus Anatomy 0.000 description 19
- 241001465754 Metazoa Species 0.000 description 17
- 210000004185 liver Anatomy 0.000 description 17
- 244000061520 Angelica archangelica Species 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 208000019255 Menstrual disease Diseases 0.000 description 14
- 210000001015 abdomen Anatomy 0.000 description 14
- 210000003734 kidney Anatomy 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 231100000614 poison Toxicity 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 13
- 239000000463 material Substances 0.000 description 13
- 210000003101 oviduct Anatomy 0.000 description 13
- 206010062717 Increased upper airway secretion Diseases 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 208000026435 phlegm Diseases 0.000 description 12
- 206010061218 Inflammation Diseases 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 230000005906 menstruation Effects 0.000 description 11
- 206010007247 Carbuncle Diseases 0.000 description 10
- 206010013935 Dysmenorrhoea Diseases 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 240000007651 Rubus glaucus Species 0.000 description 10
- 241000736199 Paeonia Species 0.000 description 9
- 208000007893 Salpingitis Diseases 0.000 description 9
- 230000006378 damage Effects 0.000 description 9
- 230000004054 inflammatory process Effects 0.000 description 9
- 239000002574 poison Substances 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 210000001215 vagina Anatomy 0.000 description 9
- 241000762515 Hydrosalpinx Species 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 208000001848 dysentery Diseases 0.000 description 8
- 230000023597 hemostasis Effects 0.000 description 8
- 208000030843 hydrosalpinx Diseases 0.000 description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 230000010354 integration Effects 0.000 description 7
- 230000000968 intestinal effect Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 230000000452 restraining effect Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 6
- 241000588653 Neisseria Species 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 208000025747 Rheumatic disease Diseases 0.000 description 6
- 230000004087 circulation Effects 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 230000035619 diuresis Effects 0.000 description 6
- 239000007789 gas Substances 0.000 description 6
- 208000021267 infertility disease Diseases 0.000 description 6
- 201000005630 leukorrhea Diseases 0.000 description 6
- 239000002398 materia medica Substances 0.000 description 6
- 231100000862 numbness Toxicity 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 230000000552 rheumatic effect Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 206010046901 vaginal discharge Diseases 0.000 description 6
- 210000003462 vein Anatomy 0.000 description 6
- 206010000077 Abdominal mass Diseases 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 241000222122 Candida albicans Species 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 241000194017 Streptococcus Species 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 5
- SZMVKWFJCYTPOI-UHFFFAOYSA-N baicaline Natural products N1CCC2=C3OCOC3=C(OC)C3=C2C1CC1=C3C=C(OC)C(OC)=C1 SZMVKWFJCYTPOI-UHFFFAOYSA-N 0.000 description 5
- 229940095731 candida albicans Drugs 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000004209 hair Anatomy 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 208000007106 menorrhagia Diseases 0.000 description 5
- 241000192041 Micrococcus Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 208000038016 acute inflammation Diseases 0.000 description 4
- 230000006022 acute inflammation Effects 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000000306 recurrent effect Effects 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 206010000242 Abortion threatened Diseases 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 3
- 240000005001 Paeonia suffruticosa Species 0.000 description 3
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 3
- 206010034240 Pelvic congestion Diseases 0.000 description 3
- 241000588769 Proteus <enterobacteria> Species 0.000 description 3
- 208000008350 Pruritus Vulvae Diseases 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 208000005985 Threatened Abortion Diseases 0.000 description 3
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 240000008866 Ziziphus nummularia Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 208000037976 chronic inflammation Diseases 0.000 description 3
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 3
- 125000000017 cortisol group Chemical group 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000003113 dilution method Methods 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 230000001076 estrogenic effect Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000002757 inflammatory effect Effects 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 231100000682 maximum tolerated dose Toxicity 0.000 description 3
- 230000003821 menstrual periods Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 201000002266 mite infestation Diseases 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000002611 ovarian Effects 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 240000004859 Gamochaeta purpurea Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 208000004044 Hypesthesia Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000233855 Orchidaceae Species 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 206010061926 Purulence Diseases 0.000 description 2
- 206010037714 Quadriplegia Diseases 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000031737 Tissue Adhesions Diseases 0.000 description 2
- 241001615463 Trichogenes Species 0.000 description 2
- DJSISFGPUUYILV-UHFFFAOYSA-N UNPD161792 Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-UHFFFAOYSA-N 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 208000030961 allergic reaction Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- NPLTVGMLNDMOQE-UHFFFAOYSA-N carthamidin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=C(O)C(O)=C2C(=O)C1 NPLTVGMLNDMOQE-UHFFFAOYSA-N 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000003890 fistula Effects 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 208000022168 hypermenorrhea Diseases 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001114 myogenic effect Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- DJSISFGPUUYILV-ZFORQUDYSA-N scutellarin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-ZFORQUDYSA-N 0.000 description 2
- 229930190376 scutellarin Natural products 0.000 description 2
- 208000037921 secondary disease Diseases 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 238000011121 vaginal smear Methods 0.000 description 2
- 230000008016 vaporization Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 244000118350 Andrographis paniculata Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 206010028140 Mucous stools Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010050819 Musculoskeletal chest pain Diseases 0.000 description 1
- 206010051458 Myometritis Diseases 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- 206010033119 Ovarian abscess Diseases 0.000 description 1
- 244000148137 Patrinia villosa Species 0.000 description 1
- 235000019109 Patrinia villosa Nutrition 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241001062472 Stokellia anisodon Species 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 241001123263 Zostera Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000002579 anti-swelling effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000006161 blood agar Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000009989 contractile response Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 208000027692 gas pain Diseases 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000008929 jingui shenqi Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000036445 liquid secretion Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229960000715 nimodipine Drugs 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 231100000563 toxic property Toxicity 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 238000009602 toxicology test Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 239000002918 waste heat Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
菌株 | 最低抑菌浓度(MIC)(mg/ml) |
白色念珠菌 | 4.135 |
*** | 11.8 |
丙型链球菌 | 27 |
绿脓杆菌 | 5.95 |
大肠杆菌 | 51 |
卡他球菌 | 23 |
金黄色葡萄球菌 | 6.18 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310746423.3A CN103721131B (zh) | 2013-12-30 | 2013-12-30 | 一种治疗妇女慢性***的中药栓剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310746423.3A CN103721131B (zh) | 2013-12-30 | 2013-12-30 | 一种治疗妇女慢性***的中药栓剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103721131A CN103721131A (zh) | 2014-04-16 |
CN103721131B true CN103721131B (zh) | 2016-06-01 |
Family
ID=50445592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310746423.3A Active CN103721131B (zh) | 2013-12-30 | 2013-12-30 | 一种治疗妇女慢性***的中药栓剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103721131B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106038802A (zh) * | 2016-06-21 | 2016-10-26 | 杨高林 | 治疗妇女卵巢早衰的中药组合物制备方法及其组合物 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104225116A (zh) * | 2014-06-05 | 2014-12-24 | 内蒙古林业总医院 | 一种治疗妇科炎症的药物及其制备方法 |
CN104352910A (zh) * | 2014-11-05 | 2015-02-18 | 青岛恒波仪器有限公司 | 一种治疗妇女带下的中药外用栓剂及其制备方法 |
CN104667170A (zh) * | 2014-11-27 | 2015-06-03 | 青岛申达高新技术开发有限公司 | 一种治疗痛经的中药栓剂及其制备方法 |
CN104721749A (zh) * | 2015-04-01 | 2015-06-24 | 青岛大学附属医院 | 一种治疗产褥感染后的中药清洗液及其制备方法 |
CN106692722A (zh) * | 2015-11-13 | 2017-05-24 | 李佐敏 | 一种消除囊肿的中药制作方法 |
CN105395470A (zh) * | 2015-12-02 | 2016-03-16 | 山东皇圣堂药业有限公司 | 一种***填塞吸附栓 |
CN105920357A (zh) * | 2016-07-10 | 2016-09-07 | 马佳 | 治疗妇女提前闭经的中药栓剂制备方法及其栓剂 |
CN105920359A (zh) * | 2016-07-10 | 2016-09-07 | 马佳 | 一种治疗妇女卵巢早衰的中药栓剂及其制备方法 |
CN105920358A (zh) * | 2016-07-10 | 2016-09-07 | 马佳 | 一种治疗妇女提前闭经的中药栓剂及其制备方法 |
CN106177451A (zh) * | 2016-07-10 | 2016-12-07 | 马佳 | 治疗妇女卵巢早衰的中药栓剂制备方法及其栓剂 |
CN110123911A (zh) * | 2018-02-02 | 2019-08-16 | 刘光毕 | 一种治疗慢性***的中药栓剂及其制备方法 |
CN108434323A (zh) * | 2018-05-28 | 2018-08-24 | 江苏苏南药业实业有限公司 | 一种用于治疗慢性***的药物组合物及其制备方法 |
CN113813346A (zh) * | 2021-11-06 | 2021-12-21 | 张春梅 | 一种妇科外用药丸及其包裹工艺和制备方法 |
CN114504633B (zh) * | 2022-03-31 | 2022-11-01 | 宁波市中医院 | 一种用于治疗慢性盆腔痛的中药组合物、使用方法及其应用 |
CN117159674B (zh) * | 2023-11-03 | 2024-01-09 | 云南中医药大学 | 一种治疗湿热瘀阻证候的妇科中药组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101085299A (zh) * | 2006-06-07 | 2007-12-12 | 朱齐超 | 一种治疗女性***的中药组合物及其用途 |
CN102048675A (zh) * | 2010-12-15 | 2011-05-11 | 郑高育 | 一种芳草洁阴露及其制备工艺 |
CN102274433A (zh) * | 2011-08-09 | 2011-12-14 | 安徽济人药业有限公司 | 一种治疗慢性***的中药及其制备方法 |
-
2013
- 2013-12-30 CN CN201310746423.3A patent/CN103721131B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101085299A (zh) * | 2006-06-07 | 2007-12-12 | 朱齐超 | 一种治疗女性***的中药组合物及其用途 |
CN102048675A (zh) * | 2010-12-15 | 2011-05-11 | 郑高育 | 一种芳草洁阴露及其制备工艺 |
CN102274433A (zh) * | 2011-08-09 | 2011-12-14 | 安徽济人药业有限公司 | 一种治疗慢性***的中药及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106038802A (zh) * | 2016-06-21 | 2016-10-26 | 杨高林 | 治疗妇女卵巢早衰的中药组合物制备方法及其组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN103721131A (zh) | 2014-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103721131B (zh) | 一种治疗妇女慢性***的中药栓剂及其制备方法 | |
CN102178804B (zh) | 一种治疗肛周湿疹的中药组合物及其制备方法 | |
CN105535715A (zh) | 治疗湿热内蕴型湿疹的中药外洗液 | |
CN102145111A (zh) | 一种治疗霉菌性***炎的中药组合物及其制备方法 | |
WO2006076844A1 (fr) | Medicament chinois traditionnel destine a traiter les blessures resultant de chutes, rhumatisme et ostealgie et son procede de fabrication | |
CN102205026A (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN101518600B (zh) | 一种治疗细菌或真菌性皮肤病的中药组合物及其制备方法 | |
CN102178814B (zh) | 一种治疗滴虫性***炎的中药组合物及其制备方法 | |
CN103800772A (zh) | 一种防治***炎症的妇科外用洗液及其制备方法 | |
CN101167934A (zh) | 金松止痒洗液 | |
CN104274788A (zh) | 一种治疗妇女肝火湿热型带下的中药组合物及其制备方法 | |
CN102178877B (zh) | 一种治疗阴囊湿疹的外用制剂及其制备方法 | |
CN102078569B (zh) | 一种治疗肝癌的中药制剂及其制备方法 | |
CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
CN102847021B (zh) | 一种治疗溃疡性结肠炎的灌肠剂及其制备方法 | |
CN104906465A (zh) | 一种治疗妇女慢性***的中药化瘀组合物及其制备方法 | |
CN113616714A (zh) | 一种高硒抗hpv病毒的生物蛋白凝胶敷料及其制备方法 | |
CN105662996A (zh) | 治疗月经相关性痤疮的中药面膜 | |
CN103041247B (zh) | 一种治疗***炎的中药栓剂及其制备方法 | |
CN103520439B (zh) | 一种治疗热毒蕴结型慢性骨髓炎的中药及其制备方法 | |
CN106039109A (zh) | 防治寒湿阻络型的类风湿性关节炎的中药药酒 | |
CN105362839A (zh) | 一种治疗妇科炎症的中药组合物 | |
CN104706953A (zh) | 一种治疗慢性子***的中药制剂 | |
CN103721138A (zh) | 一种治疗酒糟鼻的中药外用制剂及其制备方法 | |
CN103751532A (zh) | 一种治疗妇科炎症的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160509 Address after: The city of Anshan city of Qingdao province Shandong two road 266001 No. 62 Applicant after: Zhao Yumei Address before: 266071 Shandong province Qingdao City Road No. 19 east red room unit 7 Applicant before: Qingdao Hengbo Instrument Co., Ltd. |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Ma Kaihong Inventor before: The inventor has waived the right to be mentioned |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170515 Address after: Pingtung 519000 Guangdong province Zhuhai Nanping Science and Technology Industrial Park Road 4 No. 11 B second storey factory building Patentee after: Zhuhai dry Cosmetics Co., Ltd. Address before: The city of Anshan city of Qingdao province Shandong two road 266001 No. 62 Patentee before: Zhao Yumei |